Skip to main content

Solventum Corp

SOLV
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001964738

No open-market purchases or sales by Solventum Corp insiders were filed in the last 90 days; 885 institutions reported holding it in 13F filings for Q2 2026, worth $9.84B in total; Trian Fund Management is the only superinvestor holding it.

Holders of 5% or more of SOLV

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Solventum Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SOLV
HolderLatest formStakeChangeFirst filedLatest filingFiling
3M Co13G/A14.80%25.6M shares−5.10 ppfrom 19.90%Nov 14, 20242 filingsAug 18, 2025SEC
Independent Franchise Partners LLP13G/A7.44%12.9M shares+1.58 ppfrom 5.86%Aug 13, 20252 filingsNov 13, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Solventum Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SOLV
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20258:45 AM ETIndependent Franchise Partners LLP13G/A7.44%12.9M shares+1.58 ppfrom 5.86%Sep 30, 2025SEC
Aug 18, 20255:03 PM ET3M Co13G/A14.80%25.6M shares−5.10 ppfrom 19.90%Aug 15, 2025SEC
Aug 13, 20252:38 PM ETIndependent Franchise Partners LLP13G5.86%10.1M sharesNewJun 30, 2025SEC
Nov 14, 20244:06 PM ET3M Co13G19.90%34.4M sharesNewSep 30, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Solventum Corp shares.

No Form 144 notices for Solventum Corp are on file.